At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PDX PIMCO DYNAMIC INCOME STRATEGY FUND
Closed New Year's Day 12-31 16:00:00 EST
18.78
+0.10
+0.54%
盘后18.78
+0.000.00%
16:38 EST
High18.94Low18.59Vol284.43K
Open18.59D1 Closing18.68Amplitude1.90%
Mkt Cap839.60MTradable Cap0.00Total Shares44.71M
T/O5.34MT/O Rate--Tradable Shares0.00
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Saba Capital Management Reports Sale of Pimco Dynamic Income Strategy Fund Common Shares
Reuters  ·  12-30 10:22
Saba Capital Management Reports Sale of Pimco Dynamic Income Strategy Fund Common Shares
Phillips 66 Reports Hydrotreater Upset at Sweeny, Texas, Refinery: TCEQ -- OPIS
Dow Jones  ·  2025-12-06
Phillips 66 Reports Hydrotreater Upset at Sweeny, Texas, Refinery: TCEQ -- OPIS
PIMCO Removes Kiesel as Manager of Dynamic Income Strategy Fund
Reuters  ·  2025-11-14
PIMCO Removes Kiesel as Manager of Dynamic Income Strategy Fund
HCW Biologics Presents Preclinical Data for TRBC-Based T-Cell Engager Program at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
GlobeNewswire  ·  2025-11-07
HCW Biologics Presents Preclinical Data for TRBC-Based T-Cell Engager Program at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
Preclinical Data Presented at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Support Potential of BBO-10203, a First-in-Class RAS:PI3Kα Breaker That Inhibits KRAS-Mutant Tumor Growth without Inducing Hyperglycemia
GlobeNewswire  ·  2025-10-26
Preclinical Data Presented at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Support Potential of BBO-10203, a First-in-Class RAS:PI3Kα Breaker That Inhibits KRAS-Mutant Tumor Growth without Inducing Hyperglycemia
SELLAS Life Sciences to Present In Vivo Preclinical Data Demonstrating Statistically Significant Survival Benefit of SLS009 in T-Cell Prolymphocytic Leukemia at the European Society for Medical Oncology (ESMO) Congress 2025
GlobeNewswire  ·  2025-10-13
SELLAS Life Sciences to Present In Vivo Preclinical Data Demonstrating Statistically Significant Survival Benefit of SLS009 in T-Cell Prolymphocytic Leukemia at the European Society for Medical Oncology (ESMO) Congress 2025
PIMCO Dynamic Income Strategy Fund Files Initial Beneficial Ownership Statement; Director Mark D. Michel Listed as Reporting Owner
Reuters  ·  2025-09-26
PIMCO Dynamic Income Strategy Fund Files Initial Beneficial Ownership Statement; Director Mark D. Michel Listed as Reporting Owner
Saba Capital Management Reports Disposal of Common Shares in Pimco Dynamic Income Strategy Fund
Reuters  ·  2025-09-09
Saba Capital Management Reports Disposal of Common Shares in Pimco Dynamic Income Strategy Fund
Saba Capital Management Reports Disposal of Common Shares of Pimco Dynamic Income Strategy Fund
Reuters  ·  2025-09-03
Saba Capital Management Reports Disposal of Common Shares of Pimco Dynamic Income Strategy Fund
Saba Capital Management Reports Disposal of Common Shares in Pimco Dynamic Income Strategy Fund
Reuters  ·  2025-08-14
Saba Capital Management Reports Disposal of Common Shares in Pimco Dynamic Income Strategy Fund
Kathleen Ann McCartney, Director, Reports Acquisition of Common Shares in Pimco Dynamic Income Strategy Fund
Reuters  ·  2025-07-10
Kathleen Ann McCartney, Director, Reports Acquisition of Common Shares in Pimco Dynamic Income Strategy Fund

Introduction

Company Name.
PIMCO DYNAMIC INCOME STRATEGY FUND
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Issue price:
--